Abingworth Management LTD

Average Profitability
50.73%
Insider Buys Quantity
3
Insider Buys Sum
$7.07M
Insider Sells Quantity
6
Insider Sells Sum
$3.09M

Insider Activity of Abingworth Management LTD

The largest purchase of all time was on 2012-05-04 and amounted to 1100000 shares of Supernus Pharmaceuticals, Inc. for $5.5M.

The largest sale of all time was on 2005-01-05 and amounted to 100000 shares of Alnylam Pharmaceuticals, Inc. for $869,750.

Biography of Abingworth Management LTD

No biography is available at this moment.

2012-05-04PurchaseSupernus Pharmaceuticals, Inc.
SUPN
10 percent owner
1.1M
5.478%
$5.00$5.5M+29.48%
2005-05-27PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
130,520
0.5122%
$6.00$783,120+71.97%
2005-01-18SaleAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
43,163
0.214%
$8.48$366,109+4.42%
2005-01-12SaleAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
5,000
0.0258%
$9.30$46,500-1.48%
2005-01-11SaleAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
20,000
0.1061%
$9.85$197,050-4.51%
2005-01-10SaleAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
75,000
0.354%
$9.87$739,950-15.15%
2005-01-06SaleAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
100,000
0.4892%
$8.70$869,750-0.23%
2005-01-05SaleAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
100,000
0.5287%
$8.70$869,750+7.64%
2004-05-27PurchaseAlnylam Pharmaceuticals, Inc.
ALNY
10 percent owner
130,520
1.8621%
$6.00$783,120
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.